Evaluation of new serum markers as predictors of liver fibrosis in patients with chronic liver disease irrespective of the aetiology

Background Identification of non-invasive serum fibrosis markers in liver disease is challenging. We aimed to identify a new marker panel for the identification of significant fibrosis in a large cohort of patients with chronic liver disease with mixed aetiology. Patients and methods Patients with any chronic liver disease were included in the study. Transient elastography (TE) was employed to phenotype the patients. Significant fibrosis was defined by TE results >7.5kPa and no-fibrosis by TE results